Sample Information Outcome
Sample Description Sample Type Known-Trio Approach (%) Universal Approach ChimericaID Status Hacken Sack UMC (%) Clinical Status
Zscore %
ID101_D Donor, Pre transplant Pure - 0.92 0.09 NO   NO
ID101_R Recipient, Pre transplant Pure - 1.03 0.5 NO   NO
ID101_Post8_PBL Recipient, Post transplant PBL Possible chimerism 2.9% 12.72 2.66 YES 8 YES
ID101_Post8_CD3 Recipient, Post transplant T cell receptor Possible chimerism 19.3% 89.12 16.25 YES 33 YES
ID101_Post8_CD15 Recipient, Post transplant neutrophil Possible chimerism 0.06% 0.74 0.19 NO 0 NO
ID101_Post6_PBL Recipient, Post transplant PBL Possible chimerism 3.8% 56.41 3.5 YES 6 YES
ID101_Post6_CD15 Recipient, Post transplant neutrophil Possible chimerism 0.88% 0.88 0.13 NO 0 NO
ID102_D Donor, Pre transplant Pure - 0.86 0.29 NO   NO
ID102_R Recipient, Pre transplant Pure - 0.97 0.25 NO   NO
ID102_Post13_PBL Recipient, Post transplant PBL Possible chimerism 3.15% 6.84 2.99 YES 3 YES
ID102_Post14_PBL Recipient, Post transplant PBL Possible chimerism 16.96% 80.97 16.4 YES 14 YES
ID102_Post15_PBL Recipient, Post transplant PBL Possible chimerism 9.22% 40.66 9.4 YES 16 YES
Table 5: ChimericID clinical samples.